Glavine Paul bought HELP
September 30, 2026 · Form 4 insider transaction
Glavine Paul bought 248,000 shares of Cybin D/B/A Helus Pharma, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
248,000
Price
N/A
Total value
N/A
InsiderGlavine Paul
RoleOfficer, Director
SecurityCommon Shares
Transaction codeA: Grant or award
Transaction dateSeptember 30, 2026
Filing dateOctober 1, 2026
Shares owned after4,750,191
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents grant of 248,000 restricted stock units ("RSUs") on September 30, 2026, with immediate vesting.; Each ("RSU") represents a right to receive one share of the Issuer's common stock.; Includes 230,941 shares previously reported as indirect holdings by the PLG Family Trust, which have been transferred to the Reporting Person. Due to rounding, the number of shares has been reduced to 230,939.